How to prevent outbreak of a hospital-affiliated dementia day-care facility in the pandemic COVID-19 infection in Taiwan

Huang, Hsuan-Ti; Chen, Tun‐Chieh; Liu, Tzu-Yin; Chiu, Chun-Feng; Hsieh, Wen-Chien; Yang, Chih-Jen; Chen, Yen-Hsu

doi:10.1016/j.jmii.2020.04.007

Cited by 12 publications

(7 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Prevention of COVID-9 in the elderly, particularly those with dementia, or residents of long-term care facilities requires a coordinated approach with a close collaboration between family members and health professionals. Strict environmental clearance, hand hygiene, safe distance between residents to reduce droplet contamination can prevent COVID-19 spread [35].…”

Section: Discussionmentioning

confidence: 99%

Correlations between COVID-19 and burden of dementia: An ecological study and review of literature

Azarpazhooh

Amiri

Morovatdar

et al. 2020

Journal of the Neurological Sciences

View full text Add to dashboard Cite

Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre-including this research content-immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

show abstract

Section: Discussionmentioning

confidence: 99%

Correlations between COVID-19 and burden of dementia: An ecological study and review of literature

Azarpazhooh

Amiri

Morovatdar

et al. 2020

Journal of the Neurological Sciences

View full text Add to dashboard Cite

show abstract

“…Since the first case of coronavirus disease 2019 (COVID-19), initially named 2019 novel coronavirus (2019-nCoV) pneumonia, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in Wuhan, China, the disease has affected more than 32.7 million people, with over one million fatalities worldwide [ 1 , 2 ]. To combat this global health crisis, every health authority developed and implemented numerous infection control and prevention measures including mask-wearing, practicing good hand hygiene, social distancing, avoiding crowded areas, active identification and quarantine of close contacts, and rapid set-up of shelter hospital and lock down strategies 3 , 4 , 5 , 6 , 7 . These aggressive management measures in response to COVID-19 brought additional benefits in terms of reducing other infections.…”

Section: Introductionmentioning

confidence: 99%

Increased antimicrobial resistance during the COVID-19 pandemic

Lai

Chen

et al. 2021

International Journal of Antimicrobial Agents

326

217

View full text Add to dashboard Cite

In addition to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the current status of the coronavirus disease 2019 (COVID-19) pandemic. There has been a rapid increase in multidrug resistant organisms (MDROs), including extended-spectrum β-lactamases-producing Klebsiella pneumoniae , carbapenem-resistant New Delhi metallo-β-lactamase-producing Enterobacterales, Acinetobacter baumannii , methicillin-resistant Staphylococcus aureus , pan-echinocandin-resistant Candida glabrata, and multi-triazole-resistant Aspergillus fumigatus . The cause is multifactorial and particularly related to high rates of antimicrobial agent utilization in COVID-19 patients with a relatively low rate of co- or secondary infection. Appropriate prescription and optimized use of antimicrobials according to the principles of antimicrobial stewardship program, quality diagnosis, and aggressive infection control measures may help prevent the occurrence of MDROs during this pandemic.

show abstract

“…In contrast, the global effort to combat COVID-19, particularly the strict implementation of public health control measures, provides some collateral benefit of reducing the spread of other infectious diseases [ 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 ]. In Japan, cases of seasonal influenza were lower in 2020 than in previous years, which could be associated with the seasonal temperature (local climate), viral virulence, and measures taken to constrain the SARS-CoV-2 outbreak [ 17 ].…”

Section: Introductionmentioning

confidence: 99%

The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis

Lai

Chen

Yen

et al. 2021

Travel Medicine and Infectious Disease

View full text Add to dashboard Cite

Introduction The impact of the COVID-19 pandemic on the incidence of notifiable infectious diseases (NIDs) in Taiwan remains unclear. Materials and Methods The number of cases of NID (n = 42) between January and September 2019 and 2020 were obtained from the open database from Taiwan Centers for Disease Control. Results The number of NID cases was 21,895 between January and September 2020, which was lower than the number of cases during the same period in 2019 (n = 24,469), with a decline in incidence from 102.9 to 91.7 per 100,000 people in 2019 and 2020, respectively. Fourteen airborne/droplet, 11 fecal-oral, seven vector-borne, and four direct-contact transmitted NID had an overall reduction of 2,700 (-28.1%), 156 (-23.0%), 557 (-54.8%), and 73 (-45.9%) cases, respectively, from 2019 to 2020. Similar trends were observed for the changes in incidence, which were 11.5 (-28.4%), 6.7 (-23.4%), 2.4 (-55.0%), and 0.3 (-46.2%) per 100,000 people for airborne/droplet, fecal-oral, vector-borne, and direct-contact transmitted NID, respectively. In addition, all the 38 imported NID showed a reduction of 632 (-73.5%) cases from 2019 to 2020. In contrast, 4 sexually transmitted diseases (STDs) showed an increase of 903 (+7.2%) cases from 2019 to 2020, which was attributed to the increase in gonorrhea (from 3,220 to 5,028). The overall incidence of STDs increased from 52.5 to 56.0 per 100,000 people, with a percentage change of +6.7%. Conclusion This study demonstrated a collateral benefit of COVID-19 prevention measures for various infectious diseases, except STDs, in Taiwan, during the COVID-19 epidemic.

show abstract

How to prevent outbreak of a hospital-affiliated dementia day-care facility in the pandemic COVID-19 infection in Taiwan

Cited by 12 publications

References 5 publications

Correlations between COVID-19 and burden of dementia: An ecological study and review of literature

Correlations between COVID-19 and burden of dementia: An ecological study and review of literature

Increased antimicrobial resistance during the COVID-19 pandemic

The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis

Contact Info

Product

Resources

About